{
    "sec_cik": "0001578845",
    "sec_company_name": "Actavis plc (Filer)",
    "document_type": "EX991",
    "sec_form_header": "Form 8-K",
    "sec_period_of_report": "20150224",
    "sec_filing_date": "20150225",
    "sec_changed_date": "20150225",
    "sec_accepted_date": "20150225082005",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/1578845/000119312515061188/0001193125-15-061188-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/1578845/000119312515061188/0001193125-15-061188.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0004\004\AGN_0001578845_EX991_20150224_EX-99_metadata.json",
    "original_file_name": "",
    "original_file_size": "20805 chars",
    "document_group": "EX-99",
    "section_name": "EX-99",
    "section_n_characters": 16262,
    "endpoints": [
        "EX-99.1   ",
        "Actavis, Allergan, their respective directors and certain of their executive officers and employees may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the Actavis and Allergan shareholders in connection with the proposed merger is set forth in the joint proxy statement/prospectus. Information about the directors and executive officers of Allergan is set forth in its proxy statement for its 2014 annual meeting of stockholders, which was filed with the SEC on March 26, 2014 and certain of its Current Reports on Form 8-K. Information about the directors and executive officers of Actavis is set forth in Actavis’ proxy statement for its 2014 annual meeting of shareholders, which was filed with the SEC on March 28, 2014 and certain of Actavis’ Current Reports on Form 8-K. Additional information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, is contained in the joint proxy statement/prospectus filed with the above-referenced registration statement on Form S-4 and other relevant materials to be filed with the SEC when they become available."
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "AGN",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0004\004\AGN_0001578845_EX991_20150224_EX-99_excerpt.txt",
    "time_elapsed": 0.0,
    "batch_number": 4,
    "batch_signature": "",
    "batch_start_time": "2023-04-16 21:15:41.037609",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-16 21:27:16.390393"
}